To the full analysis
FMC stock: growth
FMCFMC reported $3.47B in revenue for fiscal 2025, down 18.3% on the prior year, down 5.7% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
2.1%
per year from 2006 to 2025, per share 3.2%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | −5.7% | 0.6% | 2.1% |
| Revenue per share | −5.0% | 1.2% | 3.2% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $2.35B | $132M | $139.4M |
| 2007 | $2.63B | $132.4M | $154.2M |
| 2008 | $3.12B | $304.6M | $132.8M |
| 2009 | $2.83B | $228.5M | $140.3M |
| 2010 | $3.12B | $172.5M | $212.2M |
| 2011 | $3.38B | $365.9M | $191.8M |
| 2012 | $3.75B | $416.2M | $153.1M |
| 2013 | $3.87B | $293.9M | $106.8M |
| 2014 | $3.26B | $307.5M | $149M |
| 2015 | $3.28B | $489M | −$466.2M |
| 2016 | $3.28B | $209.1M | $367M |
| 2017 | $2.88B | $535.8M | $249.8M |
| 2018 | $4.29B | $502.1M | $211.8M |
| 2019 | $4.61B | $477.4M | $394.6M |
| 2020 | $4.64B | $552.4M | $580.6M |
| 2021 | $5.05B | $739.6M | $720M |
| 2022 | $5.8B | $736.5M | $440.1M |
| 2023 | $4.49B | $1.32B | −$520.3M |
| 2024 | $4.25B | $339.9M | $603.2M |
| 2025 | $3.47B | −$2.24B | −$176.5M |
Revenue by segment
How FMC Corporation makes its money and how that has shifted. Names are as the company reports them.
- Insecticides45%
- Herbicides36%
- Fungicides10%
- Plant Health6%
- Other3%
“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies.
Figures as a table
| 2021 | 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|---|
| Insecticides | $3.02B | $3.35B | $2.64B | $2.38B | $1.57B | 45.4% |
| Herbicides | $1.38B | $1.65B | $1.28B | $1.28B | $1.25B | 36% |
| Fungicides | $325.5M | $383.9M | $317.6M | $352.5M | $362.8M | 10.5% |
| Plant Health | $216.8M | $234.1M | $186.9M | $200.5M | $190.9M | 5.5% |
| Other | $107.6M | $186.1M | $64.5M | $0 | $94.1M | 2.7% |
| Total revenue | $5.05B | $5.8B | $4.49B | $4.25B | $3.47B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 11 Jul 2025)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.